Zhu Sheng-lang, Li Jiu-hong, Chen Lu, Bao Zhong-xian, Zhang Long-jiang, Li Jia-ping, Chen Jie-hui, Ji Kun-mei
Department of Nephrology, Shenzhen Nanshan Hospital, Shenzhen, China.
Pediatrics. 2009 Jun;123(6):e1099-102. doi: 10.1542/peds.2008-3659.
In this article we report our experience with the diagnostic screening and management of children with melamine-induced nephrolithiasis.
A total of 1091 children younger than 4 years who had been exposed to melamine-contaminated formula from September 17 to October 12, 2008, were screened for nephrolithiasis at the department of pediatrics at Shenzhen Nanshan Hospital in China. During the clinical examination, each patient's demographic characteristics were recorded together with the details of his or her milk-consumption profile during the contamination scare and any clinical signs of poisoning. Urinary stones were detected by B-ultrasonography, and renal status was examined by a routine urine test panel and a renal function test. When urinary stones were detected, patients were ordered to cease consumption of the suspected formula, and a conservative treatment course was adopted, including infusion of fluids, urinary alkalinization, increased water consumption, and diuresis.
Of the 1091 children screened, 12 (1.1%) were diagnosed with kidney stones. They had been exposed to the contaminated milk from 1 to 24 months. Eleven (91.7%) of these 12 patients had consumed milk with a high level of melamine content (955-2563 ppm); 1 patient (8.3%) had consumed milk with a low-level melamine content (6.2-17.0 ppm). Six patients exhibited dysuria; the remaining 6 patients were asymptomatic. All 12 patients had normal renal function, although 4 had proteinuria, and 1 had hematuria. The kidney stones were resolved within 3 to 5 days of commencing treatment in all 12 cases.
Nephrolithiasis was associated with high melamine-exposure levels. A combination of B-ultrasonography and urinalysis is suitable for screening for pediatric nephrolithiasis caused by melamine poisoning. The condition can be resolved with a conservative treatment approach in patients without serious clinical symptoms who have normal kidney function.
在本文中,我们报告了对三聚氰胺所致肾结石患儿进行诊断性筛查及治疗的经验。
2008年9月17日至10月12日期间接触过受三聚氰胺污染配方奶粉的1091名4岁以下儿童在中国深圳南山医院儿科接受了肾结石筛查。在临床检查期间,记录了每位患者的人口统计学特征以及在污染恐慌期间其牛奶摄入情况的详细信息和任何中毒临床症状。通过B超检测尿路结石,并通过常规尿检和肾功能检查来评估肾脏状况。当检测到尿路结石时,要求患者停止食用可疑配方奶粉,并采取保守治疗方案,包括补液、碱化尿液、增加饮水量和利尿。
在1091名接受筛查的儿童中,12名(1.1%)被诊断为肾结石。他们接触受污染牛奶的时间为1至24个月。这12名患者中有11名(91.7%)食用了三聚氰胺含量高的牛奶(955 - 2563 ppm);1名患者(8.3%)食用了三聚氰胺含量低的牛奶(6.2 - 17.0 ppm)。6名患者出现排尿困难;其余6名患者无症状。所有12名患者肾功能均正常,尽管有4名患者有蛋白尿,1名患者有血尿。所有12例患者在开始治疗后3至5天内肾结石均消失。
肾结石与高三聚氰胺暴露水平相关。B超检查和尿液分析相结合适用于筛查三聚氰胺中毒所致小儿肾结石。对于肾功能正常且无严重临床症状的患者,采用保守治疗方法可解决该病症。